If the second test was lower than the first, but still above the normal range, the cancer incidence was 4.35% (3.66–5.04) for CRP, 3.55% (2.86–4.24) for ESR and 3.28% (1.79–4.78) for PV. The gene discussed is ESR1; the disease is cancer.